The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index.
The Clonal Evolution of Tumor Cell Populations: Acquired genetic lability permits stepwise selection of variant sublines and underlies tumor progression.
Abstract
It is proposed that most neoplasms arise from a single cell of origin, and tumor progression results from acquired genetic variability within the original clone allowing sequential selection of more aggressive sublines. Tumor cell populations are apparently more genetically unstable than normal cells, perhaps from activation of specific gene loci in the neoplasm, continued presence of carcinogen, or even nutritional deficiencies within the tumor. The acquired genetic insta0ility and associated selection process, most readily recognized cytogenetically, results in advanced human malignancies being highly individual karyotypically and biologically. Hence, each patient's cancer may require individual specific therapy, and even this may be thwarted by emergence of a genetically variant subline resistant to the treatment. More research should be directed toward understanding and controlling the evolutionary process in tumors before it reaches the late stage usually seen in clinical cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mutations enabling rapid proliferation are selected positively in cancers because they accelerate the emergence of aggressive phenotypes through somatic evolution.1,2”
From Dynamic IL-6R/STAT3 signaling leads to heterogeneity of metabolic phenotype in pancreatic ductal adenocarcinoma cells (2024) · cites this paper as [2]
Citations
Cites
Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,592
Normal genetically mosaic mice produced from malignant teratocarcinoma cells.
Mintz, B., & Illmensee, K. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3585 · Cited by 1,179
Handbuch der allgemeinen pathologie
(1973) · Experimental Gerontology · doi:10.1016/0531-5565(73)90021-1 · Cited by 794
Glucose-6-Phosphate Dehydrogenase Mosaicism: Utilization as a Cell Marker in the Study of Leiomyomas
Linder, D., & Gartler, S. M. (1965) · Science · doi:10.1126/science.150.3692.67 · Cited by 398
Differentiation of malignant to benign cells
Kauffman, S. A. (1971) · Journal of Theoretical Biology · doi:10.1016/0022-5193(71)90020-8 · Cited by 309
Suppression of malignancy in human cells
Stanbridge, E. J. (1976) · Nature · doi:10.1038/260017a0 · Cited by 307
Methodology in mammalian genetics
Burdette, W. J. (1963) · Holden-Day eBooks · doi:10.5962/bhl.title.6428 · Cited by 302
LEVAN, A., Levan, G., & Mitelman, F. (2009) · Hereditas · doi:10.1111/j.1601-5223.1977.tb01208.x · Cited by 263
The analysis of malignancy by cell fusion: I. hybrids between tumour cells and l cell derivatives
Klein, G., Bregula, U., Wiener, F., & Harris, H. (1971) · Journal of Cell Science · doi:10.1242/jcs.8.3.659 · Cited by 248
Neoplasia: a disease of cell differentiation.
Markert, C. L. (1968) · PubMed · Cited by 244
Flagged first, then by citations
1 of the 52 references couldn’t be matched to a known paper.
Research works printed but not linked: 24
- ALSAADI, A, SEQUENTIAL CYTOGENETIC CHANGES IN EVOLUTION OFTRANSPLANTED THYROID TUMORS IN METASTATIC CARCINOMA IN FICHER RAT, CANCER RESEARCH 27: 1831 (1967).
- BOYSE, E.A., CURRENT RES ONCOLOGY: 57 (1972).
- DIPAOLO, J.A., KARYOLOGICAL INSTABILITY OF NEOPLASTIC SOMATIC-CELLS, IN VITRO-JOURNAL OF THE TISSUE CULTURE ASSOCIATION 11: 89 (1975).
- FOLKMAN, J, S FUNDAMENTAL ASPECT: 331 (1975).
- FURTH, J, NATIONAL CANCER INSTITUTE MONOGRAPHS 2: 148 (1960).
- GERMAN, J, GENES WHICH INCREASE CHROMOSOMAL INSTABILITY IN SOMATIC CELLS AND PREDISPOSE TO CANCER, PROGRESS IN MEDICAL GENETICS 8: 61 (1972).
- GOLUB, S.H., CANCER COMPREHENSIVE 4: 259 (1975).
- GROUCHY, J.D., CHROMOSOMES CANCER: 287 (1974).
- HANDEN, D.G., CHROMOSOMES CANCER: 151 (1974).
- KLEIN, G, METHODOLOGY MAMMALIA: 407 (1963).
- KNUDSON, A.G., HEREDITY AND CANCER IN MAN, PROGRESS IN MEDICAL GENETICS 9: 113 (1973).
- MAKINO, S, ANN N Y ACAD SCI 64: 818 (1956).
- Miller, E. C., The Molecular Biology of Cancer: 377 (1974).
- NOWELL, P.C., CANCER COMPREHENSIVE 1: 3 (1975).
- NOWELL, P.C., CHROMOSOMES CANCER J: 267 (1974).
- ODELL, W, TXB ENDOCRINOLOGY: 1105 (1974).
- Oksala, T., Chromosomes and Cancer: 239 (1974).
- Pedersen, B., Proceedings of the Fourth International Congress on Human Genetics: 166 (1972).
- Pitot, H. C., Molecular Biology of Cancer: 523 (1974).
- Robbins, J. C., Cancer: A Comprehensive Treatise 4: 3 (1975).
- RUBIN, H, SCIENCE 191: 241 (1976). · DOI
- STICH, H.F., CANADIAN CANCER CONFERENCE 5: 99 (1963).
- WOLMAN, S.R., CANCER COMPREHENSIVE 3: 155 (1975).
- Yosida, T. H., Handbuch der Allgemeinen Pathologic: 677 (1975).
Cited by
Sorted by citations
Items 801–900 of 1,016
Cytogenetics of Synovial Sarcoma: Presentation of Ten New Cases and Review of the Literature
Limon, J., Mrózek, K., Mandant, N., Nedoszytko, B., Verhest, A. P., Ryś, J., Niezabitowski, A., Babińska, M., Nosek, H., Ochalek, T., et al. (1991) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870030504 · Cited by 123
Rudrapatna, V. A., Cagan, R. L., & Das, T. K. (2011) · Developmental Dynamics · doi:10.1002/dvdy.22771 · Cited by 126
Dynamics of Tumor Heterogeneity Derived from Clonal Karyotypic Evolution
Laughney, A. M., Elizalde, S., Genovese, G., & Bakhoum, S. F. W. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.065 · Cited by 120
Transcription Factor/microRNA Axis Blocks Melanoma Invasion Program by miR-211 Targeting NUAK1
Bell, R. E., Khaled, M., Netanely, D., Schubert, S., Golan, T., Buxbaum, A., Janas, M. M., Postolsky, B., Goldberg, M. S., Ron Shamir, A., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.340 · Cited by 125
SPhyR: tumor phylogeny estimation from single-cell sequencing data under loss and error
El-Kebir, M. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty589 · Cited by 122
Chui, M. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27745 · Cited by 122
Clonal evolution of acute leukemia genomes
Jan, M., & Majeti, R. (2012) · Oncogene · doi:10.1038/onc.2012.48 · Cited by 129
Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing
Yu, C., Yu, J. Q., Yao, X., Wu, W. K. K., Lu, Y., Tang, S., Li, X., Bao, L., Li, X., Hou, Y., et al. (2014) · Cell Research · doi:10.1038/cr.2014.43 · Cited by 124
Yen, C.-Y., Huang, H., Shu, C., Hou, M., Yuan, S. F., Wang, H.-R., Chang, Y.-T., Farooqı, A. A., Tang, J., & Chang, H. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.036 · Cited by 120
Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance
Schmidt, F., & Efferth, T. (2016) · Pharmaceuticals · doi:10.3390/ph9020033 · Cited by 121
Zaccaria, S., & Raphael, B. J. (2020) · Nature Communications · doi:10.1038/s41467-020-17967-y · Cited by 113
From DNA damage to mutations: All roads lead to aging
Vijg, J. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101316 · Cited by 133
An Epigenetic Role of Mitochondria in Cancer
Liu, Y., Chen, C., Wang, X., Sun, Y., Zhang, J., Chen, J., & Shi, Y. (2022) · Cells · doi:10.3390/cells11162518 · Cited by 131
Defective DNA Repair in Cells With Human T-Cell Leukemia/Bovine Leukemia Viruses: Role of tax Gene
Philpott, S. M., & Buehring, G. C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.933 · Cited by 121
Serrated Pathway and APC (Conventional)-Type Colorectal Polyps
Goldstein, N. S. (2005) · American Journal of Clinical Pathology · doi:10.1309/87bd0c6ucgug236j · Cited by 121
Perspectives on the Role of Mhc Antigens in Normal and Malignant Cell Development
Elliott, B. E., Carlow, D. A., Rodricks, A.-M., & Wade, A. (1989) · Advances in cancer research · doi:10.1016/s0065-230x(08)60282-1 · Cited by 121
Rozhok, A. I., & DeGregori, J. V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1501713112 · Cited by 119
Guo, M., Ren, J., House, M. G., Qi, Y., Brock, M. V., & Herman, J. G. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2858 · Cited by 120
Time, telomeres and tumours: is cellular senescence more than an anticancer mechanism?
Wright, W. E., & Shay, J. W. (1995) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)89044-3 · Cited by 119
Real‐time cell cycle imaging during melanoma growth, invasion, and drug response
Haass, N. K., Beaumont, K. A., Hill, D. S., Anfosso, A., Mrass, P., Munoz, M. A., Kinjyo, I., & Weninger, W. (2014) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12274 · Cited by 119
Cancer Metastasis: A Reappraisal of Its Underlying Mechanisms and Their Relevance to Treatment
Riggi, N., Aguet, M., & Stamenkovic, I. (2017) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-044127 · Cited by 121
Cancer-Derived Exosomes as Effectors of Key Inflammation-Related Players
Othman, N., Jamal, R., & Abu, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02103 · Cited by 121
Crucial Role of Interleukin-4 in the Survival of Colon Cancer Stem Cells
Francipane, M. G., Alea, M. P., Lombardo, Y., Todaro, M., Medema, J. P., & Stassi, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6874 · Cited by 120
Distance-Based Reconstruction of Tree Models for Oncogenesis
Desper, R., Jiang, F., Kallioniemi, O., Moch, H., Papadimitriou, C. H., & Schäffer, A. A. (2000) · Journal of Computational Biology · doi:10.1089/10665270050514936 · Cited by 117
Aneuploidy Precedes and Segregates with Chemical Carcinogenesis
DUESBERG, P. H., Li, R., Rasnick, D., Rausch, C., Willer, A., Kraemer, A., Yerganian, G., & Hehlmann, R. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00236-8 · Cited by 116
A New View of Carcinogenesis and an Alternative Approach to Cancer Therapy
López‐Lázaro, M. (2009) · Molecular Medicine · doi:10.2119/molmed.2009.00162 · Cited by 120
Mechanisms of Tumor Promotion: Potential Role of Intercellular Communication
Trosko, J. E., Chang, C., & Medcalf, A. S. C. (1983) · Cancer Investigation · doi:10.3109/07357908309020276 · Cited by 119
Kerbel, R. S., Waghorne, C. G., Man, M. S., Elliott, B. E., & Breitman, M. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1263 · Cited by 119
Emerging Understanding of Multiscale Tumor Heterogeneity
Gerdes, M. J., Sood, A., Sevinsky, C. J., Pris, A. D., Zavodszky, M. I., & Ginty, F. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00366 · Cited by 125
The Evolution of Lifespan and Age-Dependent Cancer Risk
Rozhok, A. I., & DeGregori, J. V. (2016) · Trends in cancer · doi:10.1016/j.trecan.2016.09.004 · Cited by 117
Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment
Eguchi, T., Sogawa, C. A., Okusha, Y., Uchibe, K., Iinuma, R., Ono, K., Nakano, K., Murakami, J., Itoh, M., Arai, K., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191109 · Cited by 123
Kohsaka, S., Petronczki, M. P., Solca, F., & Maemondo, M. (2018) · Future Oncology · doi:10.2217/fon-2018-0736 · Cited by 123
The “life code”: A theory that unifies the human life cycle and the origin of human tumors
Liu, J. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.09.005 · Cited by 120
Mutagenesis induced by the tumor microenvironment
Yuan, J., & Glazer, P. M. (1998) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00042-6 · Cited by 118
Cancer stem cells: a model in the making
Marotta, L. L. C., & Polyák, K. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.12.003 · Cited by 119
Nikitin, A. Y., Juarez-Perez, M. I., Li, S., Huang, L., & Lee, W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3916 · Cited by 118
Salisbury, J. L., Whitehead, C. M., Lingle, W. L., & Barrett, S. L. (1999) · Biology of the Cell · doi:10.1016/s0248-4900(99)80086-0 · Cited by 119
A human homolog of the Schizosaccharomyces pombe rad9 + checkpoint control gene
Lieberman, H. B., Hopkins, K. M., Nass, M., Demetrick, D. J., & Davey, S. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13890 · Cited by 116
Edwards, P. A. (1985) · British Journal of Cancer · doi:10.1038/bjc.1985.24 · Cited by 118
Intratumour Heterogeneity in Urologic Cancers: From Molecular Evidence to Clinical Implications
Gerlinger, M., Catto, J. W. F., Orntoft, T. F., Real, F. X., Zwarthoff, E. C., & Swanton, C. (2014) · European Urology · doi:10.1016/j.eururo.2014.04.014 · Cited by 124
Immunodominance and tumor escape
Schreiber, H. W., Wu, T. H., Nachman, J. B., & Kast, W. M. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0401 · Cited by 117
Gorunova, L., Höglund, M., Andrén‐Sandberg, Å., Dawiskiba, S., Jin, Y., Mitelman, F., & Johansson, B. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199810)23:2 · Cited by 118
Single cell analysis of cancer genomes
Loo, P. V., & Voet, T. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.12.004 · Cited by 118
BitPhylogeny: a probabilistic framework for reconstructing intra-tumor phylogenies
Yuan, K., Sakoparnig, T., Markowetz, F. M., & Beerenwinkel, N. (2015) · Genome biology · doi:10.1186/s13059-015-0592-6 · Cited by 119
Cancer Stem Cells: Cellular Plasticity, Niche, and its Clinical Relevance
Lee, G., & Hall, R. R. (2016) · Journal of Stem Cell Research & Therapy · doi:10.4172/2157-7633.1000363 · Cited by 123
All biology is computational biology
Markowetz, F. M. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2002050 · Cited by 116
Predictive validity in drug discovery: what it is, why it matters and how to improve it
Scannell, J. W., Bosley, J., Hickman, J. A., Dawson, G. R., Truebel, H., Ferreira, G. S., Richards, D. B., & Treherne, J. M. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00552-x · Cited by 126
Review of Chromium (VI) Apoptosis, Cell-Cycle-Arrest, and Carcinogenesis
Chiu, A. O. S., Shi, X., LEE, W. K. P., Hill, R., Wakeman, T. P., Katz, A. J., Xu, B., Dalal, N. S., Robertson, J. D., Chen, C., et al. (2010) · Journal of Environmental Science and Health Part C · doi:10.1080/10590501.2010.504980 · Cited by 122
Fatouros, M., Baltoyiannis, G., & Roukos, D. H. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9612-4 · Cited by 115
Aktipis, A. (2011) · Evolution and Human Behavior · doi:10.1016/j.evolhumbehav.2011.01.002 · Cited by 120
Metastasis Predictive Signature Profiles Pre-exist in Normal Tissues
Yang, H., Crawford, N. P. S., Lukes, L., Finney, R., Lancaster, M., & Hunter, K. W. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-6244-6 · Cited by 115
Cancer Genomes Evolve by Pulverizing Single Chromosomes
Meyerson, M., & Pellman, D. (2011) · Cell · doi:10.1016/j.cell.2010.12.025 · Cited by 115
Experimental systems for analysis of the malignant phenotype
Poste, G. H. (1982) · Cancer and Metastasis Reviews · doi:10.1007/bf00048224 · Cited by 115
Single-cell mutational profiling and clonal phylogeny in cancer
Potter, N. E., Ermini, L., Papaemmanuil, E., Cazzaniga, G., Vijayaraghavan, G., Titley, I., Ford, A., Campbell, P., Kearney, L., & Greaves, M. (2013) · Genome Research · doi:10.1101/gr.159913.113 · Cited by 107
Wu, Y., Basir, Z., Kajdacsy-Balla, A., Strawn, E., Macias, V., Montgomery, K., & Guo, S.-W. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(02)04821-5 · Cited by 114
Oltean, S., Sorg, B. S., Albrecht, T. R., Bonano, V. I., Brazas, R. M., Dewhirst, M. W., & García-Blanco, M. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603090103 · Cited by 114
Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer.
Zardawi, S. J., O'Toole, S. A., Sutherland, R. L., & Musgrove, E. A. (2009) · PubMed · doi:10.14670/hh-24.385 · Cited by 111
Origin of carcinoma associated fibroblasts
Haviv, I., Polyák, K., Qiu, W., Hu, M., & Campbell, I. (2009) · Cell Cycle · doi:10.4161/cc.8.4.7669 · Cited by 118
Chronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies
Clarkson, B., Strife, A., Wisniewski, D. J., Lambek, C. L., & Liu, C. (2003) · Leukemia · doi:10.1038/sj.leu.2402912 · Cited by 115
Pericellular Matrix in Malignant Transformation
Alitalo, K. K., & Vaheri, A. I. (1982) · Advances in cancer research · doi:10.1016/s0065-230x(08)60883-0 · Cited by 113
Zafar, H., Navin, N. E., Chen, K., & Nakhleh, L. K. (2019) · Genome Research · doi:10.1101/gr.243121.118 · Cited by 113
Somatic Mutagenesis in Mammals and Its Implications for Human Disease and Aging
Zhang, L., & Vijg, J. (2018) · Annual Review of Genetics · doi:10.1146/annurev-genet-120417-031501 · Cited by 108
Classical pathology and mutational load of breast cancer – integration of two worlds
Budczies, J., Bockmayr, M. L., Denkert, C., Klauschen, F., Lennerz, J. K., Győrffy, B., Dietel, M., Loibl, S., Weichert, W., & Stenzinger, A. (2015) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.25 · Cited by 114
The impact of intra-clonal heterogeneity on the treatment of multiple myeloma
Brioli, A., Melchor, L., Cavo, M., & Morgan, G. J. (2014) · British Journal of Haematology · doi:10.1111/bjh.12805 · Cited by 116
Stieber, D., Golebiewska, A., Evers, L., Lenkiewicz, E., Brons, N. H. C., Nicot, N., Oudin, A., Bougnaud, S., Hertel, F., Bjerkvig, R., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1196-4 · Cited by 112
Advancing a clinically relevant perspective of the clonal nature of cancer
Ruiz, C. F., Lenkiewicz, E., Evers, L., Holley, T., Robeson, A., Kiefer, J., Demeure, M. J., Hollingsworth, M. A., Shen, M., Prunkard, D. E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104009108 · Cited by 111
Zapata, L., Pich, O., Serrano, L. G., Kondrashov, F. A., Ossowski, S., & Schaefer, M. H. (2018) · Genome biology · doi:10.1186/s13059-018-1434-0 · Cited by 110
Mapping the spreading routes of lymphatic metastases in human colorectal cancer
Zhang, C., Zhang, L., Xu, T., Xue, R., Yu, L., Zhu, Y.-L., Wu, Y., Zhang, Q., Li, D., Shen, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15886-6 · Cited by 112
How protons pave the way to aggressive cancers
Swietach, P., Boedtkjer, E., & Pedersen, S. F. (2023) · Nature reviews. Cancer · doi:10.1038/s41568-023-00628-9 · Cited by 118
Hypoxia-inducible factors and hypoxic cell death in tumour physiology
Bacon, A., & Harris, A. L. (2004) · Annals of Medicine · doi:10.1080/07853890410018231 · Cited by 113
Riethmüller, G., & Klein, C. A. (2001) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0386 · Cited by 112
Elsässer, H. P., Lehr, U., Agricola, B., & Kern, H. F. (1992) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890431 · Cited by 112
Genomic instability induced by high and low let ionizing radiation
Limoli, C. L., Ponnaiya, B., Corcoran, J., Giedzinski, E., Kaplan, M. I., Hartmann, A., & Morgan, W. F. (2000) · Advances in Space Research · doi:10.1016/s0273-1177(99)01062-5 · Cited by 112
Braune, S., Krüger‐Genge, A., Kammerer, S., Jung, F., & Küpper, J. (2021) · Life · doi:10.3390/life11020091 · Cited by 116
Using single-cell sequencing technology to detect circulating tumor cells in solid tumors
Xu, J., Liao, K., Yang, X., Wu, C., & Wu, W. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01392-w · Cited by 116
Canine malignant hemangiosarcoma as a model of primitive angiogenic endothelium
Fosmire, S. P., Dickerson, E. B., Scott, A., Bianco, S. R., Pettengill, M. J., Meylemans, H. A., Padilla, M. L., Frazer‐Abel, A. A., Akhtar, N., Getzy, D. M., et al. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700080 · Cited by 111
Roschke, A. V., Stover, K., Tonon, G., Schäffer, A. A., & Kirsch, I. R. (2002) · Neoplasia · doi:10.1038/sj.neo.7900197 · Cited by 111
Replacement of the p16/CDKN2 gene suppresses human glioma cell growth.
Arap, W., Nishikawa, R., Furnari, F. B., Cavenee, W. K., & Huang, H.-J. S. (1995) · PubMed · Cited by 111
Farber, E. (1981) · New England Journal of Medicine · doi:10.1056/nejm198112033052304 · Cited by 111
Dr Jekyll and Mr Hyde: role of aneuploidy in cellular adaptation and cancer
Pavelka, N., Rancati, G. I., & Li, R. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2010.06.003 · Cited by 110
Suh, M. S., Lee, W. W., Kim, Y., Yun, P., & Kim, S. E. (2016) · Radiology · doi:10.1148/radiol.2016152294 · Cited by 110
The translational challenges of precision oncology
Pich, O., Bailey, C., Watkins, T. B. K., Zaccaria, S., Jamal‐Hanjani, M., & Swanton, C. (2022) · Cancer Cell · doi:10.1016/j.ccell.2022.04.002 · Cited by 116
An error catastrophe in cancer?
Solé, R. V., & Deisboeck, T. S. (2004) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2003.08.018 · Cited by 108
Kim, Y., Petko, Z., Dzieciatkowski, S., Li, L., Ghiassi, M., Stain, S., Chapman, W. C., Washington, M. K., Willis, J. E., Markowitz, S. D., et al. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20341 · Cited by 110
Altered DNA Methylation: A Secondary Mechanism Involved in Carcinogenesis
Goodman, J. I., & Watson, R. E. (2002) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.092001.141143 · Cited by 110
Schneider, P. M., Casson, A. G., Levin, B., Garewal, H. S., Hoelscher, A. H., Becker, K., Dittler, H. J., Cleary, K. R., Troster, M., Siewert, J. R., et al. (1996) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(96)70441-5 · Cited by 110
Pre-cancerous steps in carcinogenesis Their physicological adaptive nature
Farber, E. (1984) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(83)90002-1 · Cited by 110
Olsson, L., & Forchhammer, J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.11.3389 · Cited by 110
Cellular heterogeneity in tumours
Woodruff, M. F. A. (1983) · British Journal of Cancer · doi:10.1038/bjc.1983.96 · Cited by 110
Maloney, D. G., Kaminski, M. S., BUROWSKI, D., Haimovich, J., & Levy, R. (1985) · Hybridoma · doi:10.1089/hyb.1985.4.191 · Cited by 110
The bad seed: Cancer stem cells in tumor development and resistance
Koren, E., & Fuchs, Y. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.06.006 · Cited by 112
Intratumoral heterogeneity and drug resistance in cancer
Fu, Y.-C., Liang, S.-B., Luo, M., & Wang, X. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03734-w · Cited by 129
The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer
Hansen, L. T., Lundin, C., Spang‐Thomsen, M., Pétersen, L. N., & Helleday, T. (2003) · International Journal of Cancer · doi:10.1002/ijc.11106 · Cited by 109
Hüettel, B., Kreil, D. P., Matzke, M. A., & Matzke, A. J. M. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000226 · Cited by 109
Induction of Chromosomal Instability by Chronic Oxidative Stress
Limoli, C. L., & Giedzinski, E. (2003) · Neoplasia · doi:10.1016/s1476-5586(03)80027-1 · Cited by 109
Klein, A. M., Brash, D. E., Jones, P. H., & Simons, B. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909738107 · Cited by 109
Methylation reveals a niche: stem cell succession in human colon crypts
Kim, K., & Shibata, D. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205604 · Cited by 104
Grosovsky, A. J., Parks, K. K., Giver, C. R., & Nelson, S. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.11.6252 · Cited by 109
Whitworth, P. W., Pak, C. C., Esgro, J. J., Kleinerman, E. S., & Fidler, I. J. (1990) · Cancer and Metastasis Reviews · doi:10.1007/bf00052607 · Cited by 109
Roby, K. A. W., Brumbaugh, J. A., Biehl, J., Holtzer, H., & Boettiger, D. E. (1977) · Cell · doi:10.1016/0092-8674(77)90299-9 · Cited by 109
Metadata
- Authors
- Nowell, P. C.
- Affiliations
- School of Medicine, University of Pennsylvania, Philadelphia 19174.
- Venue
- Science
- Published
- 1976-10
- Volume
- 194
- Issue
- 4260
- Pages
- 23-28
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1967304777
- Cited by
- 6,471
- References
- 52
- Citations by year
- 2026: 117 · 2025: 163 · 2024: 183 · 2023: 201 · 2022: 209 · 2021: 282 · 2020: 287 · 2019: 259 · 2018: 304 · 2017: 332 · 2016: 263 · 2015: 261 · 2014: 241 · 2013: 233 · 2012: 200
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Keywords
- clonal evolution, tumor progression, karyotypic heterogeneity, tumor cell populations, treatment resistance, carcinogen exposure, precision oncology
- MeSH terms
- Carcinogens, Chromosomes, Clone Cells, Karyotyping, Models, Biological, Mutation, Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review